Correlation Between Quest PharmaTech and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Quest PharmaTech and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quest PharmaTech and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quest PharmaTech and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Quest PharmaTech and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quest PharmaTech with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quest PharmaTech and Fennec Pharmaceuticals.
Diversification Opportunities for Quest PharmaTech and Fennec Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Quest and Fennec is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quest PharmaTech and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Quest PharmaTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quest PharmaTech are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Quest PharmaTech i.e., Quest PharmaTech and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between Quest PharmaTech and Fennec Pharmaceuticals
Assuming the 90 days horizon Quest PharmaTech is expected to under-perform the Fennec Pharmaceuticals. In addition to that, Quest PharmaTech is 1.05 times more volatile than Fennec Pharmaceuticals. It trades about -0.07 of its total potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 983.00 in Fennec Pharmaceuticals on September 14, 2024 and sell it today you would lose (367.00) from holding Fennec Pharmaceuticals or give up 37.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Quest PharmaTech vs. Fennec Pharmaceuticals
Performance |
| Timeline |
| Quest PharmaTech |
| Fennec Pharmaceuticals |
Quest PharmaTech and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quest PharmaTech and Fennec Pharmaceuticals
The main advantage of trading using opposite Quest PharmaTech and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quest PharmaTech position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.| Quest PharmaTech vs. Coya Therapeutics, Common | Quest PharmaTech vs. Cue Biopharma | Quest PharmaTech vs. Lantern Pharma | Quest PharmaTech vs. Fennec Pharmaceuticals |
| Fennec Pharmaceuticals vs. Molecular Partners AG | Fennec Pharmaceuticals vs. MediciNova | Fennec Pharmaceuticals vs. Anebulo Pharmaceuticals | Fennec Pharmaceuticals vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |